Vaccine Technologies Market, By Technology (Live-attenuated vaccines, Inactivated vaccines, Subunit vaccines, Toxoid vaccines, Viral vector vaccines, and Messenger RNA (mRNA) vaccines), By Disease Indication (Infectious Diseases and Non-Infectious Diseases), By Route of Administration (Parenteral, Oral, and Nasal ), By Age Group (Pediatric and Adult), By Distribution Channel (Public Sector and Private Sector), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
Vaccine technology refers to the methods and strategies used to create vaccines. Vaccines are biological substances that can improve immunity to a particular disease. They prepare the body's immune system to fight off specific infections. Vaccine technologies have witnessed remarkable advancements, revolutionizing disease prevention. These innovative methods utilize various approaches such as mRNA, viral vector, protein subunit, and DNA-based platforms. Unlike traditional vaccines, these cutting-edge technologies enable rapid development and adaption to emerging pathogens. By stimulating the immune system to recognize and combat specific diseases, these vaccines offer promising avenues to tackle global health challenges more effectively. As a result, the landscape of immunization has evolved, ushering in a new era of proactive and precise disease control. Vaccine technologies includes live-attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, viral vector vaccines, messenger rna (mrna) vaccines.
Market Dynamics:
Increasing product approval by the regulatory authorities is expected to drive the growth of the global vaccine technologies market over the forecast period. For instance, in December 2022, Takeda Pharmaceutical Company Limited, a multinational pharmaceutical company, announced that the European Commission (EC) had granted marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in individuals from four years of age in the European Union (EU). Moreover, in June 2021, CanSinoBIO, a biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has the trade name Menphecia. Menphecia delivers protection against infection with Group A and C Neisseria meningitides.
Key features of the study:
- This report provides an in-depth analysis of the global vaccine technologies market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the vaccine technologies market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Sanofi, Novavax, GSK, Sinovac Biotech, Bharat Biotech, Emergent BioSolutions, Dynavax Technologies, CureVac, Valneva, and Takeda Pharmaceutical Company Limited.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global vaccine technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vaccine technologies market
- Global Vaccine Technologies Market Segmentation, By Technology:
- Live-attenuated vaccines
- Inactivated vaccines
- Subunit vaccines
- Toxoid vaccines
- Viral vector vaccines
- Messenger RNA (mRNA) vaccines
- Global Vaccine Technologies Market Segmentation, By Disease Indication:
- Infectious Diseases
- Non-Infectious Diseases
- Global Vaccine Technologies Market Segmentation, By Route of Administration:
- Parenteral
- Oral
- Nasal
- Global Vaccine Technologies Market Segmentation, By Age Group:
- Pediatric
- Adult
- Global Vaccine Technologies Market Segmentation, By Distribution Channel:
- Public Sector
- Private Sector
- Global Vaccine Technologies Market Segmentation, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profile:
- Pfizer-BioNTech
- Moderna
- Johnson & Johnson
- AstraZeneca
- Sanofi
- Novavax
- GSK
- Sinovac Biotech
- Bharat Biotech
- Emergent BioSolutions
- Dynavax Technologies
- CureVac
- Valneva
- Takeda Pharmaceutical Company Limited
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Vaccine Technologies, By Technology
- Market Vaccine Technologies, By Disease Indication
- Market Vaccine Technologies, By Route of Administration
- Market Vaccine Technologies, By Age Group
- Market Vaccine Technologies, By Distribution Channel
- Market Vaccine Technologies, By Geography
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Global Health Concerns and Pandemics
- Restraints
- Regulatory Challenges
- Opportunities
- Increasing License Agreement among Key Market Players
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Vaccine Technologies Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Vaccine Technologies Market, By Technology, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Live-attenuated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Inactivated vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Subunit vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Toxoid vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Viral vector vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Messenger RNA (mRNA) vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 6. Global Vaccine Technologies Market, By Disease Indication, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Non-Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 7. Global Vaccine Technologies Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 8. Global Vaccine Technologies Market, By Age Group, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 9. Global Vaccine Technologies Market, By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Public Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Private Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- 10. Global Vaccine Technologies Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 –2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution , 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
- 11. Competitive Landscape
- Pfizer-BioNTech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Moderna
- Johnson & Johnson
- AstraZeneca
- Sanofi
- Novavax
- GSK
- Sinovac Biotech
- Bharat Biotech
- Emergent BioSolutions
- Dynavax Technologies
- CureVac
- Valneva
- Takeda Pharmaceutical Company Limited
- Analyst Views
- 12. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on "Global Vaccine Technologies Market” - Global forecast to 2030
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook